PMC - PharMerica Corporation

NYSE - NYSE Delayed Price. Currency in USD
29.25
+0.05 (+0.17%)
At close: 4:02PM EST
Stock chart is not supported by your current browser
Previous Close29.20
Open29.20
Bid0.00 x 0
Ask0.00 x 0
Day's Range29.20 - 29.27
52 Week Range0.08 - 29.50
Volume1,371,608
Avg. Volume264,287
Market Cap910.266M
Beta0.63
PE Ratio (TTM)48.03
EPS (TTM)0.61
Earnings DateFeb 22, 2018 - Feb 26, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est29.13
Trade prices are not sourced from all markets
  • American City Business Journals3 hours ago

    Here's how much PharMerica's CEO, other leaders got for their shares after acquisition

    The all-cash acquisition of PharMerica Corp. by a joint venture of KKR & Co. L.P. and Walgreens Boots Alliance Inc. was completed last week. As part of the merger agreement, all stock options and awards for PharMerica executives and directors have become fully vested and converted into the right to cash in as well. After the completion of the acquisition was announced on Dec. 7, 12 of the company's top executives and directors sold their stock and filed disclosures with the U.S. Securities and Exchange Commission the next day.

  • GuruFocus.com4 days ago

    Pharmerica Corp (PMC) CEO Gregory S Weishar Sold $15.2 million of Shares

    CEO of Pharmerica Corp (NYSE:PMC) Gregory S Weishar sold 521,089 shares of PMC on 12/07/2017 at an average price of $29.25 a share.

  • American City Business Journals8 days ago

    Walgreens, KKR complete $1.4 billion acquisition of PharMerica

    A joint venture between KKR & Co. L.P. and Walgreens Boots Alliance Inc. has completed its acquisition of Louisville-based institutional pharmacy provider PharMerica Corp. in a $1.4 billion deal. PharMerica (PMC) shareholders will receive $29.25 per share for their stock in the company, which will cease trading on the New York Stock Exchange tomorrow. PharMerica announced the merger in August and said the deal would be completed in early 2018.

  • Business Wire8 days ago

    KKR Completes Acquisition of PharMerica

    PharMerica Corporation today announced the completion of the acquisition of PharMerica by a newly formed company controlled by KKR with an affiliate of Walgreens Boots Alliance, Inc.

  • PharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : November 17, 2017
    Capital Cube28 days ago

    PharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : November 17, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for PharMerica Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Why PharMerica Corporation (PMC) Delivered An Inferior ROE Compared To The Industry
    Simply Wall St.last month

    Why PharMerica Corporation (PMC) Delivered An Inferior ROE Compared To The Industry

    PharMerica Corporation (NYSE:PMC) delivered a less impressive 4.28% ROE over the past year, compared to the 14.78% return generated by its industry. Though PMC’s recent performance is underwhelming, it isRead More...

  • Associated Presslast month

    PharMerica posts 3Q profit

    On a per-share basis, the Louisville, Kentucky-based company said it had profit of 10 cents. Earnings, adjusted for amortization costs and costs related to mergers and acquisitions, were 46 cents per share. ...

  • Business Wirelast month

    PharMerica Reports Third Quarter 2017 Results

    PharMerica Corporation , a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today reported its financial results for the third quarter ended September 30, 2017.

  • American City Business Journalslast month

    PharMerica shareholders vote on $1.4 billion acquisition

    Shareholders of Louisville-based PharMerica Corp. voted overwhelmingly to approve the company's $1.4 billion acquisition by KKR & Co. L.P. and Walgreens Boots Alliance. More than 99 percent of the votes cast, representing about 79 percent of PharMerica's common shares as of Sept. 28 (the record date for the special meeting), were in favor of adopting the merger agreement, according to a news release. The deal calls for PharMerica to be acquired by a new company controlled by KKR, a New York City-based private-equity firm, with Deerfield, Ill.-based Walgreens Boots Alliance Inc. (WBA) as a minority investor.

  • Business Wirelast month

    PharMerica Announces Approval of Merger by Stockholders

    PharMerica Corporation , announced that at its special meeting of stockholders held today, a majority of the outstanding shares of PharMerica common stock voted to approve the adoption of the previously disclosed definitive merger agreement pursuant to which a newly formed company controlled by KKR, with Walgreens Boots Alliance, Inc.

  • PharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : November 7, 2017
    Capital Cubelast month

    PharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : November 7, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for PharMerica Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Capital Cube2 months ago

    PharMerica Corp. – Value Analysis (NYSE:PMC) : October 30, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives PharMerica Corp. a score of 47. Our analysis is based on comparing PharMerica Corp. with the following peers – Walgreens Boots Alliance Inc, CVS Health Corporation, BioScrip, Inc., Rite Aid Corporation, Kindred Healthcare, Inc., AmerisourceBergen Corporation, SunLink Health Systems, Inc. and Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited ... Read more (Read more...)

  • PharMerica Corp. breached its 50 day moving average in a Bearish Manner : PMC-US : October 27, 2017
    Capital Cube2 months ago

    PharMerica Corp. breached its 50 day moving average in a Bearish Manner : PMC-US : October 27, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for PharMerica Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Business Wire2 months ago

    Onco360 Selected for VERZENIO® Limited Distribution Pharmacy Network

    Onco360, the nation’s largest independent Oncology Pharmacy, announced today that it has been selected to participate in the limited distribution network for Eli Lilly and Company’s new product, VERZENIOTM , a twice daily oral cyclin-dependent kinase 4/6 inhibitor approved by the U.S.

  • American City Business Journals2 months ago

    PharMerica details millions in golden parachute money for executives

    PharMerica Corp. executives could receive millions from the company if they are terminated after the completion of its planned $1.4 billion acquisition. The so-called "golden parachute compensation" for the company's named executives could total about $27.7 million, according to a filing with the U.S. Securities and Exchange Commission. PharMerica has agreed to be acquired by a new company, Phoenix Parent Holdings Inc., which is controlled by New York-based KKR & Co. L.P., with Deerfield, Ill.-based Walgreens Boots Alliance Inc. (WBA) as a minority investor.

  • PR Newswire2 months ago

    Faruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against PharMerica Corporation

    NEW YORK, Oct. 3, 2017 /PRNewswire/ -- Notice is hereby given that Faruqi & Faruqi, LLP has filed a class action lawsuit in the United States District Court for the District of Delaware, case No. 1:17-cv-01301, on behalf of shareholders of PharMerica Corporation ("PharMerica" or the "Company") (PMC) who have been harmed by PharMerica's and its board of directors' (the "Board") alleged violations of Sections 14(a) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") in connection with  the proposed merger of the Company with affiliates of Kohlberg Kravis Roberts & Co. L.P. ("KKR").

  • PharMerica Corp. :PMC-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017
    Capital Cube3 months ago

    PharMerica Corp. :PMC-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017

    Categories: Yahoo FinanceGet free summary analysis PharMerica Corp. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 592 million, Net Earnings of USD 4.70 million. Gross margins narrowed from 14.16% to 13.46% compared to the same period last year, operating (EBITDA) margins now 5.84% from 6.12%. Change in operating cash ... Read more (Read more...)

  • Moody's3 months ago

    PharMerica Corporation -- Moody's assigns B2 CFR to PharMerica Corporation; outlook stable

    Rating Action: Moody's assigns B2 CFR to PharMerica Corporation; outlook stable. Global Credit Research- 12 Sep 2017. New York, September 12, 2017-- Moody's Investors Service today assigned a B2 Corporate ...

  • PR Newswire3 months ago

    SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of PharMerica Corporation -- PMC

    NEW YORK , Sept. 7, 2017 /PRNewswire/ --  Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a boutique securities firm headquartered at the Empire State Building in New York ...

  • TheStreet.com3 months ago

    Private Briefing: KKR's Healthcare Deal Spree

    The healthcare team led by James Momtazee has been very busy, with deals for PharMerica, American Medical Response and Covenant Surgical Partners, among others.

  • Envision Healthcare Hurt by High Debt, Increasing Expenses
    Zacks4 months ago

    Envision Healthcare Hurt by High Debt, Increasing Expenses

    Envision Healthcare's (EVHC) increasing debt and expenses continue to hurt. Further guidance cut by the company is concerning.

  • ACCESSWIRE4 months ago

    Featured Company News - Global Investment Firm KKR and Walgreens Boots Alliance Acquire Institutional Pharmacy Services Company PharMerica

    LONDON, UK / ACCESSWIRE / August 4, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for PharMerica Corp. (NYSE: PMC ), following which we have published ...

  • PharMerica Corp.: Strong price momentum but will it sustain?
    Capital Cube4 months ago

    PharMerica Corp.: Strong price momentum but will it sustain?

    Categories: Yahoo FinancePharMerica Corp. relative valuation is OVERVALUED and it has a fundamental analysis score of 47. Our analysis is based on comparing PharMerica Corp. with the following peers – Walgreens Boots Alliance Inc, CVS Health Corporation, BioScrip, Inc., Rite Aid Corporation, Kindred Healthcare, Inc., SunLink Health Systems, Inc., AmerisourceBergen Corporation and Guangzhou Baiyunshan Pharmaceutical Holdings Company ... Read more (Read more...)

  • Business Wire4 months ago

    Bragar Eagel & Squire, P.C. Is Investigating the Board of Directors of PharMerica Corporation (PMC) on Behalf of Stockholders and Encourages Investors to Contact the Firm

    Bragar Eagel & Squire, P.C. is investigating potential claims on behalf of PharMerica Corporation stockholders concerning the proposed acquisition of the company by KKR & Co.